The drug advisory committee, Drug Science, has appointed Professor Mike Barnes as clinical lead for its flagship medical cannabis programme, Project Twenty21. The project aims to...
US-based Open Book Extracts is in the process of achieving compliance with novel food regulations as it prepares to make its move on the European market....
Seth Rogan has announced this week that he will be launching his cannabis and homeware brand, Houseplant, in the US. The comedian, writer, producer and actor,...
Research from University College London (UCL) reveals that one large dose of CBD does not change brain activity in a number of regions of the brain...
A UK campaign group claims politicians are risking the health of millions if stricter legislation of whole-plant CBD products is introduced. In a letter to the ...
Two months before the deadline for novel food applications, smaller CBD brands describe feeling “completely disregarded” as the industry appears to take another step towards “shutting...
Drugs targeting the endocannabinoid system hold promise as a novel painkiller, say researchers. Researchers in the US are exploring treatments that could reduce pain amongst chemotherapy...
A major Australian health fund has become one of the first to publicly announce its support for medical cannabis access and research. Private health insurer Health...
Kanabo, an Israeli medicinal cannabis company, is expecting to become the first cannabis firm to list on the London Stock Exchange. On the condition that...
Children are being put at ‘significant risk’ by changes to their cannabis treatment, a highly-regarded specialist in paediatric epilepsy, has told Cannabis Health. Dr Evan Cole Lewis,...